US Pharma MarketingWhy one venture investor is going from
Redesign Health rebrands from venture studio to venture firm as AI accelerates startup building, per Head of Ventures Neil Patel. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for in…
As AI makes it a lot quicker for founders to build startups from scratch, venture studios are being forced to adapt.
Redesign Health has traditionally come up with startup ideas internally, before tapping a founder ...
Source: Endpoints News